With STAT3 now linked to HR impairment and BRCAness in EBV-transformed cells and also known to be constitutively active in a variety of cancers [31], we asked if a STAT3-gene signature could predict susceptibility of cancers to synthetic lethal approaches. The gene discussed is STAT3; the disease is cancer.